Brief Introduction
Dr. Yu-Hsuan Shih is an attending physician in the Division of Medical Oncology at Taichung Veterans General Hospital, Taiwan. His clinical interests include pancreatic, gastric, and biliary tract cancers, with a focus on systemic therapy and multidisciplinary care. He is involved in clinical research in gastrointestinal oncology.
Specialty
- Gastric cancer
- Pancreatic cancer
- Biliary tract cancer
Education
- 2004 to 2011: Kaohsiung Medical University, MD degree
- 2021 to 2023: Institute of Medicine, Chung Shan Medical University, Master degree
Experience
- 2019 - 2023: Attending Physician, Division of Hematology/Oncology, Department of Internal Medicine, Taichung Veterans General Hospital
- 2023 - Present: Attending Physician, Division of Medical Oncology, Department of Oncology, Taichung Veterans General Hospital
Selected Publications
- Po-Wei Liao, Shao-Bin Cheng, Cheng-Wei Chou, Hsin-Chen Lin, Cheng-Hsien Lin, Tsung-Chih Chen, Chiann-Yi Hsu, Chieh-Lin Jerry Teng, Yu-Hsuan Shih. Chemotherapy for Metastatic Gastric Cancer: Does Age Matter? A Single-Center, Retrospective, Real-World Study. Clin Med Insights Oncol. 2022 Sep 18:16:11795549221123617.
- Yu-Hsuan Shih, Hsin-Chen Lin, Po-Wei Liao, Cheng-Wei Chou, Cheng-Hsien Lin, Chiann-Yi Hsu, Chieh-Lin Jerry Teng, Feng-Hsu Wu, Shao-Ciao Luo & Shao-Hsuan Kao. The efficacy of adjuvant chemotherapy for older adults with stage II/III gastric cancer: a retrospective cohort study. BMC Cancer. 2023 Aug 18;23(1):770.
- Hsin-Chen Lin, Kuan-Yu Tseng, Yu-Hsuan Shih. Real-world effectiveness of durvalumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in advanced gallbladder cancer: a study using the TriNetX global network. Ther Adv Med Oncol. 2025 Nov 7:17:17588359251393064.